Back

Assessing the benefit of a replacement implantable cardioverter-defibrillator device for primary prevention of sudden cardiac death

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Risk stratification in ventricular arrhythmias Cardioversion and Defibrillation ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor Angelo Auricchio

Cardiocentro Ticino Institute, Lugano (Switzerland)

4 More presentations in this session

Presentation thumbnail
Predicting ventricular arrhythmia inducibility in ajmaline-induced brugada type I pattern: validation of the dST-Tiso interval
Doctor S. Iacopino (Cotignola, IT)
Abstract Slides
Presentation thumbnail
Implantable loop recorder monitoring in inherited cardiomyopathies: yield of clinically relevant arrhythmias
Doctor A. Trancuccio (Pavia, IT)
Abstract Slides Video
Presentation thumbnail
Asymptomatic Brugada patients: long-term prognosis from a large prospective study.
Associate Professor C. Giustetto (Turin, IT)
Abstract Slides Video
Presentation thumbnail
The use of wearable cardioverter defibrillator among patients suffering from myocarditis: data from a multicenter registry
Doctor I. El-Battrawy (Bochum, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Risk stratification in ventricular arrhythmias
Video

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources